TissGeneSummary for C4orf17 |
Gene summary |
Basic gene information | Gene symbol | C4orf17 |
Gene name | chromosome 4 open reading frame 17 | |
Synonyms | - | |
Cytomap | UCSC genome browser: 4q23 | |
Type of gene | protein-coding | |
RefGenes | NM_032149.2, | |
Description | uncharacterized protein C4orf17 | |
Modification date | 20141207 | |
dbXrefs | HGNC : HGNC | |
Ensembl : ENSG00000138813 | ||
HPRD : 12825 | ||
Vega : OTTHUMG00000131027 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_C4orf17 | |
BioGPS: 84103 | ||
Pathway | NCI Pathway Interaction Database: C4orf17 | |
KEGG: C4orf17 | ||
REACTOME: C4orf17 | ||
Pathway Commons: C4orf17 | ||
Context | iHOP: C4orf17 | |
ligand binding site mutation search in PubMed: C4orf17 | ||
UCL Cancer Institute: C4orf17 | ||
Assigned class in TissGDB* | B | |
Included tissue-specific gene expression resources | HPA,TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of C4orf17 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for C4orf17 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for C4orf17 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for C4orf17 |
TissGeneSNV for C4orf17 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.P322S | SKCM | 2 |
p.M308I | SKCM | 2 |
p.C155R | UCEC | 1 |
p.V267A | PAAD | 1 |
p.E238A | KICH | 1 |
p.T269I | UCEC | 1 |
p.I19T | KIRP | 1 |
p.Q11X | SKCM | 1 |
p.T269N | CHOL | 1 |
p.Q11* | SKCM | 1 |
p.A241S | LUAD | 1 |
p.N164S | LGG | 1 |
p.D54G | BRCA | 1 |
p.R75W | LUAD | 1 |
p.P300L | UVM | 1 |
p.H231Y | SKCM | 1 |
p.D178N | UCEC | 1 |
p.P145H | STAD | 1 |
p.S265L | SKCM | 1 |
p.V336M | UCEC | 1 |
p.G284E | SKCM | 1 |
p.E343X | COAD | 1 |
p.R22I | READ | 1 |
p.L28V | BLCA | 1 |
p.E314G | STAD | 1 |
p.S154F | HNSC | 1 |
p.V29A | COAD | 1 |
p.P107T | LUAD | 1 |
p.G96E | SKCM | 1 |
p.C50F | LUSC | 1 |
p.S285C | BRCA | 1 |
p.S208L | SKCM | 1 |
p.L62F | ESCA | 1 |
p.S86G | PAAD | 1 |
p.P114H | LUAD | 1 |
p.Q328E | BLCA | 1 |
p.S156Y | LUAD | 1 |
p.K163N | COAD | 1 |
p.P101L | SKCM | 1 |
p.E273Q | BRCA | 1 |
p.P6S | SKCM | 1 |
p.P35S | SKCM | 1 |
p.G64R | SKCM | 1 |
p.E180K | SKCM | 1 |
Top |
TissGeneCNV for C4orf17 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for C4orf17 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for C4orf17 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for C4orf17 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for C4orf17 |
TissGeneDrug for C4orf17 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for C4orf17 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |